Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

HealthLynked (HLYK) Divestments (2023)

HealthLynked (HLYK) has disclosed Divestments for 1 consecutive years, with $1.2 million as the latest value for Q4 2023.

  • On a quarterly basis, Divestments changed N/A to $1.2 million in Q4 2023 year-over-year; TTM through Dec 2023 was $3.5 million, a N/A change, with the full-year FY2024 number at $425000.0, down 87.88% from a year prior.
  • Divestments was $1.2 million for Q4 2023 at HealthLynked, up from $360000.0 in the prior quarter.
  • In the past five years, Divestments ranged from a high of $1.2 million in Q4 2023 to a low of $360000.0 in Q3 2023.